A live webcast, if recorded, of each presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.fatetherapeutics.com. The archived webcast ...
Researchers at the New York Blood Center have made a breakthrough in understanding the body’s autoimmune response to sickle ...
AnaptysBio (ANAB) stock climbs as its antibody therapy rosnilimab meets key goals in mid-stage rheumatoid arthritis trial, ...
Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases -WAYNE, Pa., Feb. 12, 2025 ...
Given the success of the previous Research Topic 'Exploring Small Molecule Inhibitors in Cardiovascular and Cerebrovascular Diseases', we are pleased to ...
Xiao Ting, a director at Zenas BioPharma, Inc. (NASDAQ:ZBIO), has acquired 10,000 shares of the company's common stock, according to a recent filing with the Securities and Exchange Commission. The ...
ImmuPharma plc (LON:IMM – Get Free Report)’s share price shot up 23.8% on Saturday . The company traded as high as GBX 5.70 ($0.07) and last traded at GBX 4.83 ($0.06). 16,731,404 shares changed hands ...
Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune ...
Researchers at the (Belgium) have uncovered a previously unknown mechanism that regulates the immune response against parasites.
A major new study has confirmed that Covid “vaccines” act as a “trigger” for autoimmune hepatitis (AIH) – a lifelong liver disease. The study was conducted by leading scientists at The Second Hospital ...
COVID Vaccines Linked to Autoimmune Disease** In a groundbreaking development, recent research has unveiled that COVID-19 vaccines may act as a trigger for ...